SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis

Abstract Sin3A-associated protein 30 (SAP30) is a crucial component of the SIN/HDAC histone deacetylase complex and acts as a scaffold that facilitates target gene binding. SAP30 is highly expressed in various tumours; however, its role in renal cell carcinoma (RCC) remains unclear. In our study, we...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Guo, Shuwen Wang, Zitong Yang, Yu Dong, Zhinan Xia, Wei Xue, Cheng Zhang
Format: Article
Language:English
Published: BMC 2025-04-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-025-02440-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699103540248576
author Wei Guo
Shuwen Wang
Zitong Yang
Yu Dong
Zhinan Xia
Wei Xue
Cheng Zhang
author_facet Wei Guo
Shuwen Wang
Zitong Yang
Yu Dong
Zhinan Xia
Wei Xue
Cheng Zhang
author_sort Wei Guo
collection DOAJ
description Abstract Sin3A-associated protein 30 (SAP30) is a crucial component of the SIN/HDAC histone deacetylase complex and acts as a scaffold that facilitates target gene binding. SAP30 is highly expressed in various tumours; however, its role in renal cell carcinoma (RCC) remains unclear. In our study, we observed the upregulation of SAP30 in clear cell renal cell carcinoma (ccRCC) tissues, and its elevated expression was correlated with a poor prognosis. Previous research has suggested that SAP30 may influence the growth, proliferation, and apoptosis of RCC cells. Gene Ontology (GO) analysis of the downstream regulatory targets of SAP30 revealed that SAP30 suppressed the expression of MT1G, a protein that binds to p53. Mechanistically, SAP30 inhibited MT1G transcription, thereby impairing the function of MT1G in delivering zinc ions to p53, which diminished p53 activity. Moreover, reduced MT1G levels attenuated the inhibitory effect of MT1G on MDM2, further destabilizing p53. Consequently, this cascade promoted RCC progression. In conclusion, our findings indicate that SAP30 inhibits the p53 pathway through MT1G suppression, suggesting that SAP30 and MT1G are potential prognostic markers and therapeutic targets for RCC.
format Article
id doaj-art-2ac4b2bda9e54f4dbb740168ea723a10
institution DOAJ
issn 2047-783X
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj-art-2ac4b2bda9e54f4dbb740168ea723a102025-08-20T03:18:42ZengBMCEuropean Journal of Medical Research2047-783X2025-04-0130111510.1186/s40001-025-02440-7SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axisWei Guo0Shuwen Wang1Zitong Yang2Yu Dong3Zhinan Xia4Wei Xue5Cheng Zhang6Department of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityDepartment of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityDepartment of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityDepartment of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityDepartment of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityDepartment of Urology, Shengjing Hospital of China Medical UniversityDepartment of Urology, Center for Oncology Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang UniversityAbstract Sin3A-associated protein 30 (SAP30) is a crucial component of the SIN/HDAC histone deacetylase complex and acts as a scaffold that facilitates target gene binding. SAP30 is highly expressed in various tumours; however, its role in renal cell carcinoma (RCC) remains unclear. In our study, we observed the upregulation of SAP30 in clear cell renal cell carcinoma (ccRCC) tissues, and its elevated expression was correlated with a poor prognosis. Previous research has suggested that SAP30 may influence the growth, proliferation, and apoptosis of RCC cells. Gene Ontology (GO) analysis of the downstream regulatory targets of SAP30 revealed that SAP30 suppressed the expression of MT1G, a protein that binds to p53. Mechanistically, SAP30 inhibited MT1G transcription, thereby impairing the function of MT1G in delivering zinc ions to p53, which diminished p53 activity. Moreover, reduced MT1G levels attenuated the inhibitory effect of MT1G on MDM2, further destabilizing p53. Consequently, this cascade promoted RCC progression. In conclusion, our findings indicate that SAP30 inhibits the p53 pathway through MT1G suppression, suggesting that SAP30 and MT1G are potential prognostic markers and therapeutic targets for RCC.https://doi.org/10.1186/s40001-025-02440-7Transcription factorp53SAP30MT1GccRCC
spellingShingle Wei Guo
Shuwen Wang
Zitong Yang
Yu Dong
Zhinan Xia
Wei Xue
Cheng Zhang
SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
European Journal of Medical Research
Transcription factor
p53
SAP30
MT1G
ccRCC
title SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
title_full SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
title_fullStr SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
title_full_unstemmed SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
title_short SAP30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the MT1G axis
title_sort sap30 promotes clear cell renal cell carcinoma proliferation and inhibits apoptosis through the mt1g axis
topic Transcription factor
p53
SAP30
MT1G
ccRCC
url https://doi.org/10.1186/s40001-025-02440-7
work_keys_str_mv AT weiguo sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT shuwenwang sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT zitongyang sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT yudong sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT zhinanxia sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT weixue sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis
AT chengzhang sap30promotesclearcellrenalcellcarcinomaproliferationandinhibitsapoptosisthroughthemt1gaxis